| Element List | Explanation |
|---|---|
| Announcement Detail | Miral Medical Clinics Company is pleased to announce that its Al Tahlia branch in Riyadh has successfully obtained accreditation from the Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI), after fulfilling all national standards and requirements for quality and patient safety. This accreditation underscores the company’s commitment to applying the highest standards of quality and excellence in its healthcare services and reflects the success of its strategy in enhancing medical infrastructure in line with leading national and international practices. The accreditation of the Al Tahlia branch marks an important milestone towards extending these standards across the company’s current and future branches, thereby strengthening the confidence of patients, beneficiaries, and investors in Miral’s capabilities and reinforcing its position as one of the leading healthcare providers in the Kingdom. Miral Medical Clinics considers this achievement a significant milestone that supports its competitive positioning and demonstrates its ability to achieve sustainable growth in an increasingly competitive healthcare sector. The accreditation also enhances the company’s potential to attract more patients and beneficiaries and opens new opportunities for expansion in delivering services aligned with the highest recognized quality standards. This accomplishment comes within the framework of the company’s strategic vision to invest in developing its medical and administrative workforce, adopting the latest healthcare technologies, and improving operational and financial performance, thereby creating long-term value for its shareholders. The company affirms that this accreditation aligns with the objectives of Saudi Vision 2030, which prioritizes the development of the healthcare sector and the enhancement of service quality, and reflects Miral’s determination to continue investing in quality and excellence as key pillars of its future growth. Furthermore, the company clarifies that this event has no immediate material financial impact, although it is expected to generate positive indirect effects in the medium to long term by strengthening patient trust and enhancing the company’s competitiveness in the healthcare market. |